Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Histologic Study of Depressed Acne Scars Treated with Serial High-Concentration (95%) Trichloroacetic Acid

YUG, ANTHONY, MD*; LANE, JOSHUA, E., MD*; HOWARD, MICHAEL, S., MD; KENT, DAVID, E., MD

ARTICLE
Buy
SDC

BACKGROUND Acne scarring is a common manifestation that remains a therapeutic challenge to dermatologists, dermatologic surgeons, and plastic surgeons. Although multiple therapeutic modalities exist, treatment often remains inadequate. The use of high-concentration (95%) trichloroacetic acid (TCA) applied focally to atrophic acne scars has been described.

OBJECTIVE The current study confirms the utility of focal application of 95% TCA to acne scars in addition to a histologic examination of this technique.

METHODS Acne scars in three patients were treated with focal 95% TCA by serial application. Wooden applicators were used to apply TCA focally and repeated at 6-week intervals for a total of six treatments. Punch biopsies were performed at baseline and at 1 year postoperatively. Histologic examination was performed with routine hematoxylin/eosin, Masson trichrome, and Verhoeff-van Gieson staining.

RESULTS Clinical examination revealed apparent cosmetic improvement in both depth and appearance of acne scars. Patient satisfaction was high. Histologic examination demonstrated a decrease in the depth of acne scars. In addition, increased collagen fibers and fragmentation of elastic fibers were noted. There were no complications from the procedure.

CONCLUSION Focal application of high-concentration TCA to atrophic and “ice-pick” acne scars appears to produce clinical improvement. Histologic changes of this technique are described.

*Division of Dermatology, Department of Internal Medicine, Mercer University School of Medicine, Macon, Georgia

Georgia Dermatopathology Associates, Atlanta, Georgia

Address correspondence and reprint requests to: David E. Kent, MD, 308 Coliseum Drive, Suite 200, Macon, Georgia 31217, or e-mail: dekent@dsspc.com.

Anthony Yug, MD, Joshua E. Lane, MD, Michael S. Howard, MD, and David E. Kent, MD, have indicated no significant interest with commercial supporters.

© 2006 by the American Society for Dermatologic Surgery, Inc.
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website